190 results found.

Pulmonary Arterial Hypertension Clinical Trial using MK-8892

Merck Sharp & Dohme Corp. - Recruiting 18 years to 70 years.
- A Non-randomized, Single-panel, Open-label Trial to Study the Safety, Tolerability and Pharmacodynamics of MK-8892 Acute Dosing in Subjects With Moderate to Severe Pulmonary Arterial Hypertension.
MK-8892

Hypertension Clinical Trial using Telmisartan + amlodipine; hydrochlorothiazide; Placebo

Boehringer Ingelheim - Recruiting 20 years or older.
- An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80 mg and Amlodipine 5 mg and Hydrochlorothiazide 12.5 mg vs. Telmisartan 80 mg and Amlodipine 5 mg in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg and Amlodipine 5 mg.
Telmisartan + amlodipine; hydrochlorothiazide; Placebo

Hypertension Clinical Trial using Twynsta tablet

Boehringer Ingelheim - Recruiting 19 years or older.
- A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy.
Twynsta tablet

Persistent Pulmonary Hypertension of the Newborn Clinical Trial using 1 dose of sildenafil

University of North Carolina, Chapel Hill - Recruiting N/A to 364 Days.
- Pharmacokinetics of Sildenafil in Premature Infants.
1 dose of sildenafil

Diabetic Nephropathy Clinical Trial using Repository Corticotropin Injection; Placebo

Questcor Pharmaceuticals, Inc. - Recruiting 18 years or older.
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive Design Pilot Safety and Efficacy Study of H.P. Acthar Gel (Acthar) in Patients With Diabetic Nephropathy and Proteinuria..
Repository Corticotropin Injection; Placebo

Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, H Clinical Trial using Renal Artery Ablation Catheter; Cardiac Ablation

St. Jude Medical - Recruiting 18 years or older.
- A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence.
Renal Artery Ablation Catheter; Cardiac Ablation

Peripheral Artery Disease, or Hypertension Clinical Trial using nebivolol; Metoprolol succinate

Thomas Jefferson University - Recruiting 18 years or older.
- Effect of Nebivolol Compared With Metoprolol in Hypertensive Patients With Peripheral Arterial Disease.
nebivolol; Metoprolol succinate

Prehypertension, or Hypertension Clinical Trial using Control group who are advised for proper life style modification by the physician such as regular exercise and healthy diet without active intervention.; Treatment group 1(Dietary intervention); Treatment group 2(dietary and exercise intervention)

Yonsei University - Recruiting 20 years or older.
- .
Control group who are advised for proper life style modification by the physician such as regular exercise and healthy diet without active intervention.; Treatment group 1(Dietary intervention); Treatment group 2(dietary and exercise intervention)

Pulmonary Arterial Hypertension Clinical Trial using Slow-paced respiration therapy

University of Pennsylvania - Recruiting 21 years or older.
- Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension.
Slow-paced respiration therapy

Essential Hypertension Complicated by Type 2 Diabetes Mellitus Clinical Trial using Azilsartan; Telmisartan

Takeda - Recruiting 20 years or older.
- A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R.
Azilsartan; Telmisartan

Compensated Alcohol-related Cirrhosis and Portal Hypertension Clinical Trial using Terlipressin acetate; Serelaxin (RLX030)

Novartis - Recruiting 18 years to 75 years.
- An Exploratory Study to Investigate the Haemodynamic Effects of Serelaxin (RLX030) in Patients With Compensated Cirrhosis and Portal Hypertension.
Terlipressin acetate; Serelaxin (RLX030)

Hypertension Clinical Trial using amlodipine/losartan

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of COZAAR XQ in Usual Practice.
amlodipine/losartan

Pulmonary Arterial Hypertension Clinical Trial

University of Arizona - Recruiting 18 years to 80 years.
- Comprehensive Characterization Of Right Ventricular Performance And Afterload In Patients With Pulmonary Arterial Hypertension Undergoing Initiation And Rapid Dose Escalation Of Treprostinil.

Pulmonary Arterial Hypertension Clinical Trial using Macitentan

Actelion - Recruiting 18 years to 80 years.
- A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument.
Macitentan

Arteriovenous Graft Clinical Trial using SRM003; Participating Site's standard practice

Shire Development LLC - Recruiting 18 years or older.
- A Phase 2, Single-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of SRM003 (Vascugelr) in the Treatment of Subjects With Vascular Injury Resulting From Arteriovenous Graft Surgery for Hemodialysis Access.
SRM003; Participating Site's standard practice

Arteriovenous Fistula Clinical Trial using SRM003; Participating Site's standard practice

Shire Development LLC - Recruiting 18 years or older.
- A Phase 2, Single-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of SRM003 (Vascugelr) in Improving the Rate of Arteriovenous Fistula Maturation and Use in Subjects Undergoing Surgery for Creation of an Arteriovenous Fistula for Hemodialysis Access.
SRM003; Participating Site's standard practice

Pulmonary Arterial Hypertension Clinical Trial using Tadalafil- Tablet

Eli Lilly and Company - Recruiting 6 Months to 17 years.
- A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension.
Tadalafil- Tablet

Hypertension Clinical Trial using Metformin; Placebo

Hospital de Clinicas de Porto Alegre - Recruiting 18 years to 75 years.
- The Hypotensive Effect of Simvastatin in Hypertensive Patients: a Placebo-controlled Randomized Clinical Trial With 24-h Ambulatory Blood Pressure Monitoring.
Metformin; Placebo

Essential Hypertension, or Hyperlipidemia Clinical Trial using Atorvastatin; Losartan; Placebo; HL-040XC

HanAll BioPharma Co., Ltd. - Recruiting 18 years to 80 years.
- A Phase 3, Randomized, Double- Blind, Multi-center, Double Dummy, Clinical Trial Comparing HL-040XC With Single Component Therapies(Atorvastatin, Losartan) to Assess the Efficacy and Safety of HL-040XC in Patients With Essential Hypertension and Hyperlipidemia.
Atorvastatin; Losartan; Placebo; HL-040XC

Hypertension, or Chronic Kidney Disease Clinical Trial using Valsartan

Novartis - Recruiting 6 years to 17 years.
- A Multicenter, Open-label, 18 Month Study to Evaluate the Long-term Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age With Hypertension and With or Without Chronic Kidney Disease.
Valsartan

Hypertension, or Cardiovascular Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 65 years.
- Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST).

Pulmonary Hypertension Clinical Trial using Ventavis inhaled (Iloprost, BAYQ6256)

Bayer - Recruiting 18 years or older.
- Open-label, Uncontrolled, Prospective Long-term Observation of Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years.
Ventavis inhaled (Iloprost, BAYQ6256)

Renal Artery Stenosis, or Hypertension, Renovascular Clinical Trial using iCASTT Rx Stent System

Atrium Medical Corporation - Recruiting 18 years or older.
- ARTISAN: iCASTT RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients With Resistant Hypertension.
iCASTT Rx Stent System

Pulmonary Hypertension Clinical Trial using Ventavis (Iloprost, BAYQ6256)

Bayer - Recruiting 18 years or older.
- Study to Assess the Compliance of Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost.
Ventavis (Iloprost, BAYQ6256)

Pulmonary Hypertension Clinical Trial using Hydroxyurea

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Hydroxyurea in Pulmonary Arterial Hypertension.
Hydroxyurea

Pulmonary Hypertension, or Sickle Cell Anemia Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients With Sickle Cell Anemia.

Caridovascular Disease, Congenital Heart Disease, or Pulmonary Hy Clinical Trial using Balloon catheter for right heart catheterization; Gadopentate Dimeglumine (Gadolinium); Contrast Agent; Right Heart Catheterization; Cardiac Real-time MRI; Vascular Hemostasis

National Institutes of Health Clinical Center (CC) - Recruiting 21 years or older.
- Real-Time MRI Right Heart Catheterization Using Passive Catheters.
Balloon catheter for right heart catheterization; Gadopentate Dimeglumine (Gadolinium); Contrast Agent; Right Heart Catheterization; Cardiac Real-time MRI; Vascular Hemostasis

Diabetes Mellitus Type 2, or Hypertension Clinical Trial using Ginseng; Wheat Bran

St. Michael's Hospital, Toronto - Recruiting 40 years to 75 years.
- Efficacy and Safety of Combined Rg3-enriched Korean Red Ginseng (Panax Ginseng C.A. Meyer) and American Ginseng (Panax Quinquefolius) as Poly-therapy in the Management of Concomitant Hypertension in Type 2 Diabetes.
Ginseng; Wheat Bran

Myeloproliferative Disorders, or Pulmonary Hypertension Clinical Trial using Echocardiography, spiroergometry, cardiac catheterization

Medical University of Graz - Recruiting 18 years to 95 years.
- Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases.
Echocardiography, spiroergometry, cardiac catheterization

Pulmonary Arterial Hypertension Clinical Trial using Dual-energy computed tomography investigation

Medical University of Graz - Recruiting 18 years or older.
- Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography - Prospective Study.
Dual-energy computed tomography investigation

Uncontrolled Hypertension Clinical Trial

St. Jude Medical - Recruiting 18 years or older.
- EnligHTN German Observational Study.

Heart Failure, or Hypertension, Pulmonary Clinical Trial using Beetroot Juice (BRJ) a botanical; placebo

Washington University School of Medicine - Recruiting 21 years or older.
- Dietary Nitrates for Heart Failure.
Beetroot Juice (BRJ) a botanical; placebo

Hypertension Clinical Trial using Amlodipine + Olmesartan medoxomil

Pfizer - Recruiting 18 years to 65 years.
- An Open Label, Non-Interventional Study Of The Safety, Tolerability, And Efficacy Of Amlodipine And Olmesartan Medoxomil (NormetecTM) In Filipino Patients With Hypertension: A Post Marketing Surveillance Study.
Amlodipine + Olmesartan medoxomil

Hypertension Clinical Trial using Ambrisentan 5 mg; Placebo

GlaxoSmithKline - Recruiting 18 years to 75 years.
- A Randomised, Multicentre, Double-Blind, Placebo-Controlled Study Of Ambrisentan In Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)..
Ambrisentan 5 mg; Placebo

Hypertension, or Dyslipidemias Clinical Trial using DASH diet counseling

Purdue University - Recruiting 40 years to 75 years.
- The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults (S31).
DASH diet counseling

Blood Pressure, or Hypertension Clinical Trial using Placebo; Oligopinr

Technological Centre of Nutrition and Health, Spain - Recruiting 18 years or older.
- Effect of a French Maritim Pine Bark Extract Oligopinr on Blood Pressure: Double Blind, Crossover, Placebo-controlled Nutrition Intervention Trial.
Placebo; Oligopinr

Isolated Systolic Hypertension Clinical Trial using SER100; Placebo

Serodus ASA - Recruiting 55 years to 80 years.
- A Randomized, Double-blind, Placebo-controlled, Cross-over, Multi-center Study Assessing the Safety, Tolerability and Efficacy of SER100 10 mg s.c. Twice Daily for 2 Days in Patients With Isolated Systolic Hypertension Insufficiently Treated With 1-3 Anti-hypertensives..
SER100; Placebo

Diabetes, or Hypertension Clinical Trial

University of North Carolina, Chapel Hill - Recruiting 18 years or older.
- A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS), an Assessment for Use in Clinical Settings Among English and Spanish-speaking Patients With Hypertension and Diabetes..

Pulmonary Hypertension Clinical Trial

Chinese Pulmonary Vascular Disease Research Group - Recruiting 15 years to 65 years.
- the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension.

Eisenmenger Syndrome Clinical Trial using Macitentan 10 mg, oral tablet, to be taken once daily.; Matching placebo oral tablet, to be taken once daily.

Actelion - Recruiting 12 years to 70 years.
- A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3 Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome..
Macitentan 10 mg, oral tablet, to be taken once daily.; Matching placebo oral tablet, to be taken once daily.

Pulmonary Hypertension, or Chronic Obstructive Pulmonary Disease Clinical Trial using Inhaled NO; Placebo

INO Therapeutics - Recruiting 40 years to 80 years.
- A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1.
Inhaled NO; Placebo

Severe Pulmonary Arterial Hypertension Clinical Trial using QTI571

Novartis - Recruiting 18 years or older.
- An Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan and Are Judged by the Investigator to Benefit From Continued QTI571 Treatment.
QTI571

Hypertension, or Aging Clinical Trial using Exercise; ACE inhibitor + exercise; Thiazide diuretic + exercise; Angiotensin receptor blocker + exercise

University of Florida - Recruiting 65 years or older.
- Multimodal Intervention to Reduce Cardiovascular Risk Among Hypertensive Older Adults.
Exercise; ACE inhibitor + exercise; Thiazide diuretic + exercise; Angiotensin receptor blocker + exercise

Atrial Fibrillation, Hypertension, Diabetes, Chronic Heart Failur Clinical Trial using Medtronic Reveal XT implantable loop recorder

Medical University of Graz - Recruiting 18 years or older.
- Randomized Controlled Trial to Evaluate Implanted Event Recorders for the First Diagnosis of Atrial Fibrillation in High-risk Patients.
Medtronic Reveal XT implantable loop recorder

Diabetes Mellitus, Type 2, or Hypertension Clinical Trial using Canagliflozin; Placebo

Janssen Scientific Affairs, LLC - Recruiting 18 years to 75 years.
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Blood Pressure Reduction With Ambulatory Blood Pressure Monitoring (ABPM), Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Hypertension and Type 2 Diabetes Mellitus.
Canagliflozin; Placebo

Nephropathy, Retinopathy, Hypertension, Obesity, or Diabetes Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 26 years or older.
- Genetics of Type 2 Diabetes in Diverse Populations.

Resistant Hypertension, or Sleep Apnea Clinical Trial using Physical activity

AGIR … Dom - Recruiting 18 years to 80 years.
- .
Physical activity

Open Angle Glaucoma, or Ocular Hypertension Clinical Trial using PG324 Ophthalmic Solution, 0.01%; PG324 Ophthalmic Solution, 0.02%; AR-13324 Ophthalmic Solution, 0.02%; Latanoprost Ophthalmic Solution, 0.005%

Aerie Pharmaceuticals - Recruiting 18 years or older.
- A Double-masked, Randomized, Controlled Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution, 0.01% and PG324 Ophthalmic Solution, 0.02%, Compared to AR-13324 Ophthalmic Solution, 0.02% and Latanoprost Ophthalmic Solution, 0.005% in Patients With Elevated Intraocular Pressure.
PG324 Ophthalmic Solution, 0.01%; PG324 Ophthalmic Solution, 0.02%; AR-13324 Ophthalmic Solution, 0.02%; Latanoprost Ophthalmic Solution, 0.005%

Glaucoma, or Ocular Hypertension Clinical Trial using bimatoprost 0.01% ophthalmic solution; bimatoprost 0.03% ophthalmic solution

Allergan - Recruiting 18 years or older.
- .
bimatoprost 0.01% ophthalmic solution; bimatoprost 0.03% ophthalmic solution

Hypertension Clinical Trial using carvedilol

University of Rochester - Recruiting 18 years to 80 years.
- Conditioned Pharmacotherapeutic Effects in Hypertension.
carvedilol

Hypertension, or Atherosclerosis Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 50 years to 90 years.
- Age-Associated Changes in Regional Adiposity and Novel Cardiovascular Risk Factors.

Insulin Resistance, or Hypertension Clinical Trial using Renal denervation using Medtronic Symplicity System (mono-electrode)

Ume† University - Recruiting 18 years or older.
- Metabolic and Cardiovascular Effects of Renal Denervation.
Renal denervation using Medtronic Symplicity System (mono-electrode)

Hypertension Clinical Trial using TELMISARTAN; NEBIVOLOL

Aristotle University Of Thessaloniki - Recruiting 18 years to 65 years.
- Comparative Study of the Effects of Telmisartan and Nebivolol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Patients With Arterial Hypertension.
TELMISARTAN; NEBIVOLOL

Pulmonary Arterial Hypertension Clinical Trial using MK-8892; Placebo for MK-8892

Merck Sharp & Dohme Corp. - Recruiting 18 years to 70 years.
- A 28-Day Multiple-Dose Titration Study to Assess the Effects of MK-8892 on Safety, Tolerability and Pharmacokinetics in Subjects With Pulmonary Arterial Hypertension.
MK-8892; Placebo for MK-8892

Pulmonary Hypertension Clinical Trial using Carvedilol; Carvedilol placebo

The Cleveland Clinic - Recruiting 18 years to 65 years.
- Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure.
Carvedilol; Carvedilol placebo

Pulmonary Arterial Hypertension Clinical Trial using UT-15C (treprostinil diethanolamine)

United Therapeutics - Recruiting 18 years to 75 years.
- Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310.
UT-15C (treprostinil diethanolamine)

Acute Coronary Syndrome, or Arterial Hypertension Clinical Trial using Renal denervation; Metoprolol; Lisinopril

Meshalkin Research Institute of Pathology of Circulation - Recruiting 18 years to 75 years.
- Renal Denervation in Patients After Acute Coronary Syndrome.
Renal denervation; Metoprolol; Lisinopril

Part 1 - Healthy Volunteers, or Part 2 - Patients With Hypertensi Clinical Trial using LFF269; Placebo to LFF269

Novartis - Recruiting 18 years to 80 years.
- A Two Part Study Including a Randomized, Double Blind, Placebo Controlled, Multiple Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LFF269 After b.i.d Dosing in Healthy Volunteers and an Open Label, Multiple Dose Pharmacokinetics Study in Hypertension Subjects.
LFF269; Placebo to LFF269

Hypertension Clinical Trial

Handok Pharmaceuticals Co., Ltd. - Recruiting 20 years or older.
- Observational Study to Investigate Resistant Hypertension Prevalence Among the Hypertensive Patients Who Have Been Treated in Korean General Hospitals.

Hypertension, High Blood Pressure, or Cardiovascular Diseases Clinical Trial using WHO CVD risk assessment package and Health Insurance; Health Insurance only

New York University School of Medicine - Recruiting 40 years or older.
- Task Shifting and Blood Pressure Control in Ghana: A Cluster-Randomized Trial.
WHO CVD risk assessment package and Health Insurance; Health Insurance only

Pulmonary Arterial Hypertension Clinical Trial using Inhaled Nitrite

University of Pittsburgh - Recruiting 18 years to 78 years.
- A Dose Escalation Study to Evaluate the Effect of Inhaled Nitrite on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Hypertension.
Inhaled Nitrite

Portal Hypertension, or Liver Disease Clinical Trial using Volumetric Flow in TIPS

University of Michigan - Recruiting 18 years or older.
- 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts.
Volumetric Flow in TIPS

Hypertension, Pulmonary Clinical Trial using Iloprost (Ventavis, BAYQ6256)

Bayer - Recruiting 18 years or older.
- Prospective Multicentre Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension.
Iloprost (Ventavis, BAYQ6256)

Hypertension Clinical Trial

Novartis - Recruiting 6 years to 17 years.
- A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1.

Ocular Hypertension, or Open-Angle Glaucoma Clinical Trial using Latanoprost Punctal Plug Delivery System (L-PPDS); Timolol Maleate GFS, 0.5%

Mati Therapeutics Inc. - Recruiting 18 years or older.
- A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma.
Latanoprost Punctal Plug Delivery System (L-PPDS); Timolol Maleate GFS, 0.5%

Pulmonary Arterial Hypertension Clinical Trial using Ventavis (Iloprost, BAYQ6256)

Bayer - Recruiting 18 years or older.
- DAILY: Observational Description of Compliance for the Daily Ventavisr Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients.
Ventavis (Iloprost, BAYQ6256)

Arterial Hypertension, or Diabetes Mellitus Clinical Trial using Conventional Holter monitoring; Implantable loop recorder

Odense University Hospital - Recruiting 65 years to 90 years.
- Detection of Subclinical Atrial Fibrillation in High Risk Patients (> 65 Years, Hypertension, Diabetes Mellitus) Using Implantable Loop Recorder.
Conventional Holter monitoring; Implantable loop recorder

Hypertension, Pulmonary Clinical Trial using Tadalafil; Placebo

Eli Lilly and Company - Recruiting 6 Months to 18 years.
- A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension.
Tadalafil; Placebo

Glaucoma, or Ocular Hypertension Clinical Trial using bimatoprost 0.01%; travatan 0.004%; timolol 0.5%; hypromellose 0.3%

Allergan - Recruiting 18 years or older.
- .
bimatoprost 0.01%; travatan 0.004%; timolol 0.5%; hypromellose 0.3%

Pulmonary Arterial Hypertension, or Hypertension, Pulmonary Clinical Trial using Sildenafil

Pfizer - Recruiting 1 year to 17 years.
- A Phase 3, Multi-Center, Open-Label Study To Investigate Safety, Efficacy, And Tolerability Of Sildenafil Citrate In Pediatric Patients With Pulmonary Arterial Hypertension.
Sildenafil

Cardiovascular Disease, Hypertension, Diabetes, or Hyperlipidemia Clinical Trial using Pharmacist CVD

Department of Veterans Affairs - Recruiting N/A or older.
- Cardiovascular Intervention Improvement Telemedicine Study.
Pharmacist CVD

Pulmonary Arterial Hypertension Clinical Trial using Beraprost Sodium 314d Modified Release Tablets; Placebo

Lung Rx - Recruiting 18 years to 80 years.
- A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvasor) in Subjects With Pulmonary Arterial Hypertension.
Beraprost Sodium 314d Modified Release Tablets; Placebo

Resistant Arterial Hypertension Clinical Trial using Sympathetic Renal Denervation; Treatment with aldactone

Parc de Salut Mar - Recruiting 18 years to 80 years.
- Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.
Sympathetic Renal Denervation; Treatment with aldactone

Atrial Fibrillation, Stroke, Hypertension, or Diabetes Clinical Trial using LOOP recorder (Medtronic LINQ device)

Rigshospitalet, Denmark - Recruiting 70 years to 90 years.
- Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals..
LOOP recorder (Medtronic LINQ device)

Hypertension, Pulmonary Clinical Trial using Excerise Training; Patient Education (Placebo)

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 82 years.
- The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Pulmonary Hypertension: Initial Studies for Establishing Guidelines.
Excerise Training; Patient Education (Placebo)

Portal Hypertension Clinical Trial using MRI Scan

University of Nottingham - Recruiting 18 years or older.
- Quantitative Magnetic Resonance Imaging (MRI) Techniques in the Evaluation and Estimation of Portal Hypertension.
MRI Scan

Abdominal Obesity Metabolic Syndrome, Insulin Resistance, or Hype Clinical Trial using Eplerenone; Placebo

Maastricht University Medical Center - Recruiting 40 years to 65 years.
- Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome.
Eplerenone; Placebo

Glaucoma, or Ocular Hypertension Clinical Trial using Bimatoprost 0.01%; Bimatoprost 0.03%

Allergan - Recruiting 18 years or older.
- .
Bimatoprost 0.01%; Bimatoprost 0.03%

Hypertension, Stroke, or Transient Ischemic Attack Clinical Trial using Nurse Practitioner Only; Nurse Practitioner + Health Coach

Visiting Nurse Service of New York - Recruiting 21 years or older.
- Center for Stroke Disparities Solution (CSDS) Project II: Community Transitions Intervention (CTI).
Nurse Practitioner Only; Nurse Practitioner + Health Coach

Open Angle Glaucoma, or Ocular Hypertension Clinical Trial using Beta-blocker monotherapy; Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution

Alcon Research - Recruiting 18 years or older.
- Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTravr in Patients Previously Uncontrolled on a Beta-blocker.
Beta-blocker monotherapy; Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution

Hypertension, Pulmonary, or Ventricular Dysfunction, Left Clinical Trial using IK-3001

INO Therapeutics - Recruiting N/A to 80 years.
- Examination of Safety and Effectiveness of IK-3001 (Nitric Oxide for Inhalation) in Japanese Subjects With Pulmonary Hypertension Associated With Cardiac Surgery - Multi-Center, Open-Label, Clinical Study.
IK-3001

Congenital Heart Disease, or Pulmonary Arterial Hypertension Clinical Trial using Sildenafil singly or in association with Bosentan

University of Sao Paulo General Hospital - Recruiting 2 Months or older.
- Combined Clinical and Surgical Approaches to Congenital Heart Disease Associated With Pulmonary Arterial Hypertension (PAH-CHD).
Sildenafil singly or in association with Bosentan

Vascular Disease Clinical Trial using ambrisentan

GlaxoSmithKline - Recruiting 18 years to 75 years.
- An Open Label Phase IIIb Study to Evaluate Efficacy and Safety of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH).
ambrisentan

Systolic Hypertension Clinical Trial using smartphone-assisted health coaching; Lifestyle counseling

York University - Recruiting 25 years to 70 years.
- Investigating Improved Self Management in Uncontrolled Systolic Hypertension.
smartphone-assisted health coaching; Lifestyle counseling

Pulmonary Arterial Hypertension Clinical Trial using PLX-PAD

United Therapeutics - Recruiting 18 years to 75 years.
- A Phase I Safety and Pharmacodynamic Study of Intravenous Infusion of PLX-PAD Cells in Patients With PAH.
PLX-PAD

Hypertension Clinical Trial

Boehringer Ingelheim Pharmaceuticals - Recruiting 18 years or older.
- Treatment Adherence to JNC 7(Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 7th Report) Guidelines in Cardiovascular (CV)-Risk Patients Across the Middle East - the Impact of Ramadan Fasting on Achieving Treatment Goals in Daily Practice.

Pulmonary Hypertension Clinical Trial using Catheterization Pacing

Stanford University - Recruiting 5 years or older.
- Investigation of Dysynchrony in Patients With Pulmonary Hypertension.
Catheterization Pacing

Pulmonary Arterial Hypertension Clinical Trial using Spironolactone; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension.
Spironolactone; Placebo

Pulmonary Hypertension Clinical Trial

Stanford University - Recruiting N/A to 18 years.
- Patient Reported Side Effects of Pulmonary Hypertension (PH) Medications.

Resistant Hypertension in Kidney Transplant Patients Clinical Trial using Chlorthalidone

Virginia Commonwealth University - Recruiting 18 years or older.
- Chlorthalidone for the Management of Resistant Hypertension in Kidney Transplant Patients.
Chlorthalidone

Ocular Hypertension Clinical Trial using Sensimed Triggersfishr

Sensimed AG - Recruiting 18 years or older.
- A Single-center, Open Label, Prospective Study Assessing the 24-hour IOP Patterns Using SENSIMED Triggerfishr in Ocular Hypertensive Patients Newly Converted to Glaucomatous Disease Versus Stable Ocular Hypertensive Patients.
Sensimed Triggersfishr

Hypertension Clinical Trial using Kona Externally Focused Ultrasound Therapy

Kona Medical Inc. - Recruiting 18 years or older.
- A Feasibility Study: An Evaluation of Renal Denervation Using Externally Focused Therapeutic Ultrasound on Patients With Refractory Hypertension.
Kona Externally Focused Ultrasound Therapy

Pulmonary Arterial Hypertension, or Congenital Heart Disease Clinical Trial using observational

Actelion - Recruiting 18 years or older.
- Adult Congenital Heart Disease Quality Enhancement Research Initiative.
observational

Hypertension Clinical Trial using Surround Sound Externally Focused Therapeutic Ultrasound

Kona Medical Inc. - Recruiting 18 years or older.
- A Feasibility Study: An Evaluation of Renal Denervation Using Externally Focused Therapeutic Ultrasound With External Targeting and Tracking on Patients With Refractory Hypertension.
Surround Sound Externally Focused Therapeutic Ultrasound

Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial using GKT137831; Placebo

Genkyotex Innovation SAS - Recruiting 18 years to 80 years.
- A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria.
GKT137831; Placebo

Vitamin K1 to Slow the Progression of Thoracic Aortic and Coronar Clinical Trial using Vitamin K1

RWTH Aachen University - Recruiting 18 years or older.
- Vitamin K1 to Slow Progression of Vascular Calcification in Hemodialysis Patients.
Vitamin K1

Essential Hypertension Clinical Trial using Placebo Single IV (Intravenous) Infusion; Experimental: Single IV Infusion Vasomera (PB1046)

PhaseBio Pharmaceuticals Inc. - Recruiting 18 years to 80 years.
- Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of VasomeraT (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension.
Placebo Single IV (Intravenous) Infusion; Experimental: Single IV Infusion Vasomera (PB1046)

Cirrhosis, Liver Fibrosis, Portal Hypertension, Cystic Fibrosis, Clinical Trial using Elastometry

Assistance Publique - H“pitaux de Paris - Recruiting 6 Months to 18 years.
- Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of FIBROSCANN..
Elastometry

Pulmonary Hypertension Clinical Trial using 3-Helium gas

Sheffield Teaching Hospitals NHS Foundation Trust - Recruiting 18 years or older.
- Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease.
3-Helium gas

Pulmonary Arterial Hypertension, HIV Infection, Congenital Heart Clinical Trial using skin biopsy; Blood Sample

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Auto-immunity and Prognosis of Pulmonary Arterial Hypertension.
skin biopsy; Blood Sample

Hyperlipidemia, or Hypertension Clinical Trial using YH16410; Rosuvastatin; Telmisartan; YH16410 placebo; Rosuvastatin placebo; Telmisartan placebo

Yuhan Corporation - Recruiting 19 years or older.
- A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia.
YH16410; Rosuvastatin; Telmisartan; YH16410 placebo; Rosuvastatin placebo; Telmisartan placebo

Pulmonary Hypertension Clinical Trial using Right Heart Catheterization

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Evaluation of Prognostic Factors and Therapeutic Targets in Pulmonary Arterial Hypertension.
Right Heart Catheterization

Type 2 Diabetes, or Hypertension Clinical Trial using Individual treatment

Odense University Hospital - Recruiting 18 years or older.
- Individually Tailored Treatment of Type 2 Diabetes.
Individual treatment

Renal Denervation, Resistant Hypertension, or Standard Medication Clinical Trial using renal denervation; standard medication

Shanghai AngioCare Medical - Recruiting 18 years to 65 years.
- Renal Denervation by Allegro System in Patients With Resistant Hypertension.
renal denervation; standard medication

Sarcoidosis, or Pulmonary Hypertension Clinical Trial using Observation

University of Cincinnati - Recruiting 18 years or older.
- Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH).
Observation

Ocular Hypertension, or Primary Open Angle Glaucoma Clinical Trial using VISION5 Product

ForSight Vision5, Inc. - Recruiting 18 years or older.
- A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension.
VISION5 Product

Portopulmonary Hypertension Clinical Trial using Ambrisentan

Tufts Medical Center - Recruiting 18 years or older.
- Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial.
Ambrisentan

Hypertension Clinical Trial using Comprehensive Intervention

Tulane University Health Sciences Center - Recruiting 21 years or older.
- Comprehensive Approach for Hypertension Prevention and Control in Argentina.
Comprehensive Intervention

Hypertension Clinical Trial using LCZ696; Olmesartan; LCZ696 matching placebo; Olmesartan matching placebo; amlodipine; hydrochlorothiazide

Novartis - Recruiting 60 years or older.
- A Randomized, Double-blind 52-week Study to Evaluate the Safety and Efficacy of an LCZ696 Regimen Compared to an Olmesartan Regimen on Arterial Stiffness Through Assessment of Central Blood Pressure in Elderly Patients With Hypertension.
LCZ696; Olmesartan; LCZ696 matching placebo; Olmesartan matching placebo; amlodipine; hydrochlorothiazide

Hypertension, Substance Abuse, Asthma, or Depression Clinical Trial

Yale University - Recruiting 18 years or older.
- Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care.

Hypertension, Hypertensive Heart Disease, Atrial Fibrillation, or Clinical Trial using Renal denervation; Medical therapy

Pace Clinic - Recruiting 55 years or older.
- Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study.
Renal denervation; Medical therapy

Open-Angle Glaucoma, or Ocular Hypertension Clinical Trial using Brinzolamide 1 %/Brimonidine 0.2% ophthalmic suspension; Timolol Maleate 0.5%

Alcon Research - Recruiting 18 years or older.
- Prospective, Randomized, Single-Center Study to Evaluate 24-hour Intraocular Pressure Control With Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination Therapy.
Brinzolamide 1 %/Brimonidine 0.2% ophthalmic suspension; Timolol Maleate 0.5%

Prehypertension Clinical Trial using Marealis refined peptide concentrate; Placebo

KGK Synergize Inc. - Recruiting 30 years to 75 years.
- A Randomized, Double-blind, Placebo Controlled, Parallel Study for the Assessment of Anti-hypertensive Effect and Safety of Marealis RPC (Refined Peptide Concentrate), in Healthy Subjects With Mild or Moderate Hypertension.
Marealis refined peptide concentrate; Placebo

Obesity, Diabetes, Hypertension, or Asthma/COPD With Tobacco Depe Clinical Trial using CHW Goal Support

University of Pennsylvania - Recruiting N/A or older.
- Community Health Worker Support to Help Patients Control Chronic Disease.
CHW Goal Support

Pulmonary Hypertension Clinical Trial

University of Chicago - Recruiting 18 years or older.
- Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator Testing.

Brain Tumors, Brain Aneurysms, or Brain AVMs Clinical Trial using Nicardipine or Esmolol

Northwestern University - Recruiting 18 years or older.
- Nicardipine Versus Esmolol for Management of Emergence Hypertension After Craniotomy.
Nicardipine or Esmolol

Hypertension Clinical Trial

Hannover Medical School - Recruiting 18 years or older.
- Electrical Baroreflex Stimulation - Sympathetic Activity.

Hypertension, Sleep Disorders, Insomnia, or Cardiovascular Diseas Clinical Trial using Online Sleep Education

University College Hospital Galway - Recruiting 18 years or older.
- Sleep to Lower Elevated Blood Pressure: A Randomised Controlled Trial.
Online Sleep Education

Hypertension Clinical Trial using Azilsartan medoximil; Placebo

University of Chicago - Recruiting 45 years to 70 years.
- Effect of Azilsartan on Aldosterone in Postmenopausal Females.
Azilsartan medoximil; Placebo

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Clinical Trial using Rituximab; Placebo

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 75 years.
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
Rituximab; Placebo

Hypertension Clinical Trial

New York University School of Medicine - Recruiting 18 years or older.
- Racial Differences in Patient-Provider Communication and Medication Adherence.

Stroke, Acute, or Progressing Stroke Clinical Trial using Phenylephrine

Samsung Medical Center - Recruiting N/A or older.
- Safety and Efficacy of Therapeutic Induced Hypertension in Patients With Acute Non-cardioembolic Ischemic Stroke: A Multicenter, Randomized, Open Label, Prospective, Phase 3 Study.
Phenylephrine

Morbid Obesity, Diabetes, or Hypertension Clinical Trial

Assuta Hospital Systems - Recruiting 14 years to 65 years.
- A Prospective Trial for Laparoscopic Adjustable Gastric Banding in Morbidly Obese Patients: Report on Weight Loss, Metabolic Changes and Quality of Life.

Hypertension, or Atrial Fibrillation Clinical Trial using renal sympathetic denervation; drug; Direct-Current Cardioversion

The First Hospital of Nanjing Medical University - Recruiting 18 years to 75 years.
- Safety and Effectiveness Study of Percutaneous Catheter-based Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation.
renal sympathetic denervation; drug; Direct-Current Cardioversion

Psoriasis, Metabolic Syndrome, Hyperlipidemia, Obesity, or Hypert Clinical Trial using Etanercept

Massachusetts General Hospital - Recruiting 18 years or older.
- Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis.
Etanercept

Uncontrolled Hypertension Clinical Trial using Ultrasound-based Renal Denervation

Sound Interventions, Inc. - Recruiting 18 years to 85 years.
- A Clinical Trial for the Assessment of Safety and Efficacy of the UltraSOUND Mediated InTerVentional Treatment of Resistant Hypertension.
Ultrasound-based Renal Denervation

Essential Hypertension Clinical Trial using renal sympathetic modification

The Second Affiliated Hospital of Chongqing Medical University - Recruiting 18 years to 75 years.
- Renal Sympathetic Modification in Patients With Essential Hypertension.
renal sympathetic modification

Hypertension Clinical Trial using Azilsartan; Amlodipine

Sogo Rinsho M‚d‚fi Co., Ltd. - Recruiting 20 years or older.
- Azilsartan Circadian and Sleep Pressure - the 1st Study.
Azilsartan; Amlodipine

Cerebrovascular Accident, or Intracranial Hypertension Clinical Trial using 3-D ultrasound scanner; Perflutren Protein-Type A Microspheres for injection

Duke University - Recruiting 18 years to 65 years.
- 3-D Transcranial Ultrasound Analysis Using Definity Injectable Suspension.
3-D ultrasound scanner; Perflutren Protein-Type A Microspheres for injection

Hypertension Clinical Trial using amlodipine/valsartan; hydrochlorothiazide/telmisartan

Yonsei University - Recruiting 20 years or older.
- .
amlodipine/valsartan; hydrochlorothiazide/telmisartan

Hypertension, or Atrial Fibrillation Clinical Trial using renal sympathetic denervation

The First Hospital of Nanjing Medical University - Recruiting 18 years to 75 years.
- Safety and Effectiveness Study of Percutaneous Catheter-based Sympathetic Denervation of the Renal Arteries in Patients With Hypertension and Paroxysmal Atrial Fibrillation.
renal sympathetic denervation

Early Gastric Cancer Clinical Trial using gastrectomy; Endoscopic submucosal dissection

National Cancer Center, Korea - Recruiting 20 years to 80 years.
- Effect of Gastrectomy and Anastomosis on Chronic Metabolic Disease Such as Diabetes and Hypertension in Early Gastric Cancer Patients.
gastrectomy; Endoscopic submucosal dissection

Tourniquet-induced Pain, or Tourniquet-induced Hypertension Clinical Trial using gabapentin 600 mg po; Placebo pill given one hour before surgery

Baylor College of Medicine - Recruiting 18 years to 64 years.
- Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension During Orif of Tibia Fracture Under General Anesthesia.
gabapentin 600 mg po; Placebo pill given one hour before surgery

Pulmonary Hypertension Clinical Trial using Spironolactone; Placebo

Baylor College of Medicine - Recruiting 18 years or older.
- Effects of Spironolactone on Collagen Metabolism in Pulmonary Arterial Hypertension.
Spironolactone; Placebo

Type 2 Diabetes, or Hypertension Clinical Trial using Step count prescription; Usual care

McGill University Health Center - Recruiting 18 years to 95 years.
- Step Monitoring to Improve ARTERial Health.
Step count prescription; Usual care

Metabolic Syndrome, or Hypertension Clinical Trial using 14 N Sodium Nitrite; 14 N Sodium Nitrate

University of Pittsburgh - Recruiting 18 years to 60 years.
- An Open-Label Study of Oral Combination of Nitrite and Nitrate in Adults With Metabolic Syndrome and Hypertension.
14 N Sodium Nitrite; 14 N Sodium Nitrate

Pulmonary Arterial Hypertension Clinical Trial using Carvedilol

The Hospital for Sick Children - Recruiting 8 years to 17 years.
- Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children.
Carvedilol

Hypertension, Pulmonary, or Pulmonary Disease, Chronic Obstructiv Clinical Trial

Wissenschaftliches Institut Bethanien e.V - Recruiting 18 years or older.
- Chronisch Obstruktive Lungenerkrankung Und Pulmonale Hypertonie: Pr„valenz Und Lebensqualit„t.

Hypertension Clinical Trial using SEVIKAR

The Catholic University of Korea - Recruiting 55 years or older.
- .
SEVIKAR

Arterial Hypertension Clinical Trial

University of Athens - Recruiting 20 years to 90 years.
- EVALUATION OF BLOOD PRESSURE MEASUREMENTS OUTSIDE OFFICE: COMPARISON OF DIAGNOSIS BASED ON EITHER AMBULATORY OR HOME BLOOD PRESSURE MEASUREMENTS.

Depressive Symptoms, Metabolic Syndrome X, Overweight, Obesity, H Clinical Trial using Generations older adult membership program; BRIGHTEN Heart Virtual Team intervention

Rush University Medical Center - Recruiting 60 years or older.
- BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome.
Generations older adult membership program; BRIGHTEN Heart Virtual Team intervention

Hemodialysis, End-stage Renal Disease, Hypertension, or Intradial Clinical Trial

University of Texas Southwestern Medical Center - Recruiting 18 years to 85 years.
- Mechanisms and Treatment of Intradialytic Hypertension - Sodium.

Essential Hypertension Clinical Trial using Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

Cardiovascular Institute & Fuwai Hospital - Recruiting 50 years to 79 years.
- Phase 4 Study of Effects of ARB Compared With Diuretics in Hypertension Patients With High Cardiovascular Risks.
Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

Type 2 Diabetes, Coronary Artery Disease, Hypertension, or Dyslip Clinical Trial using intensive control; standard control

Kyoto University, Graduate School of Medicine - Recruiting 20 years or older.
- Intensive Blood Pressure and LDL Lowering for Better Survival and Cardiovascular Outcome in Diabetic Patients With Coronary Artery Disease: Randomized Controlled Trial.
intensive control; standard control

Xerostomia, Depression, or Hypertension Clinical Trial using Malic Acid; Placebo

Universidad de Granada - Recruiting 18 years to 80 years.
- Effectiveness of Malic Acid 1% in Patients With Xerostomia Induced by Drugs. Determination of Salivary Mucins and Buffering Capacity.
Malic Acid; Placebo

Decompensated Cirrhosis, Portal Hypertension, or Bleeding Varices Clinical Trial using 8-mm covered stent group; 10-mm covered stent group

Fourth Military Medical University - Recruiting 18 years to 75 years.
- The Effect of TIPS With 8- or 10-mm Covered Stent for Preventing Variceal Rebleeding in Cirrhotic Patients..
8-mm covered stent group; 10-mm covered stent group

Hypertension Clinical Trial using spironolactone

University Hospital Olomouc - Recruiting 18 years or older.
- Addition of Spironolactone in Patients With Resistant Arterial Hypertension.
spironolactone

Persistent Pulmonary Hypertension, or Respiratory Failure Clinical Trial using Intravenous Sildenafil; Placebo

National Heart, Lung, and Blood Institute (NHLBI) - Recruiting N/A to 72 Hours.
- Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension.
Intravenous Sildenafil; Placebo

Pulmonary Arterial Hypertension Clinical Trial using udenafil; placebo

Dong-A Pharmaceutical Co., Ltd. - Recruiting 18 years or older.
- A Placebo-controlled, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH).
udenafil; placebo

Pulmonary Arterial Hypertension, or Eisenmenger Syndrome Clinical Trial using respiratory and exercise therapy

University of Heidelberg - Recruiting 18 years to 80 years.
- Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life in Patients With Severe Associated Pulmonary Arterial Hypertension (APAH) as Part of a Congenital Heart Defect With / Without Eisenmenger's Syndrome.
respiratory and exercise therapy

Abdominal Obesity, or Hypertension Clinical Trial using Moxonidine; Irbesartan

Baker IDI Heart and Diabetes Institute - Recruiting 18 years to 30 years.
- The Effect of Moxonidine and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension: a Randomised, Double Blind, Active Comparator Clinical Trial.
Moxonidine; Irbesartan

Pulmonary Arterial Hypertension, Pulmonary Hypertension, or PAH W Clinical Trial using Sitaxsentan; Bosentan, Ambrisentan

West Penn Allegheny Health System - Recruiting N/A or older.
- Pharmacogenomics in Pulmonary Arterial Hypertension: A Multi-Center International Study to Determine Whether in PAH Patients Clinical Associations Exist Between the Efficacy and Toxicity of Endothelin Receptor Antagonists and Several Gene Polymorphisms in Several Key Disease-Specific and Therapy Specific Genes.
Sitaxsentan; Bosentan, Ambrisentan

Prehypertension, or Hypertension, Stage I Clinical Trial using Ginseol Kg1 (low dose); Ginseol Kg1(high dose); Placebo

Seoul National University Hospital - Recruiting 20 years or older.
- Effect of Ginseol Kg1 on Blood Pressure Lowering in Prehypertensive or Stage I Hypertensive Patients: Multicenter, Randomized, Placebo-controlled, Double-blind Study.
Ginseol Kg1 (low dose); Ginseol Kg1(high dose); Placebo

Blood Pressure Clinical Trial using DASH diet plus exercise; ADA diet

Hospital de Clinicas de Porto Alegre - Recruiting 30 years to 90 years.
- Lifestyle Changes in Patients With Type 2 DM and Hypertension: DASH Diet and Exercise Effects.
DASH diet plus exercise; ADA diet

Stroke, or Hypertension Clinical Trial using Educational intervention for diet and physical activity; Educational message on skin cancer awareness

University of Michigan - Recruiting 18 years or older.
- Stroke Health and Risk Education (SHARE).
Educational intervention for diet and physical activity; Educational message on skin cancer awareness

Resistant Hypertension Clinical Trial using Continuous positive airway pressure

Hospital de Clinicas de Porto Alegre - Recruiting 30 years to 70 years.
- Antihypertensive Effect of Continuous Positive Airway Pressure (CPAP) in Resistant Hypertensive Patients With Sleep Apnea: Randomized Clinical Trial.
Continuous positive airway pressure

Endothelial Function, Diabetes Mellitus, or Hypertension Clinical Trial using carvedilol; metoprolol extended release

State University of New York - Downstate Medical Center - Recruiting 18 years to 80 years.
- Effect of Coreg CR on BP, Endothelial Function, Exhaled Nitric Oxide, and Nitric Oxide Production and Oxidation.
carvedilol; metoprolol extended release

Hypertension Clinical Trial using Delivery and return of chocolate; Determination of blood pressure; Anthropometric Measurements; Food Anamnesis; Samples: serological tests and culture of mononuclear cells; Analysis of cytokine production

Universidad de Antioquia - Recruiting 18 years to 65 years.
- Controlled Clinical Trial of the Effect of Cocoa Consumption in Lowering Blood Pressure and in the Modulation of Endothelial Inflammation in Hypertensive Patients Assigned to an Entity Health Promoting..
Delivery and return of chocolate; Determination of blood pressure; Anthropometric Measurements; Food Anamnesis; Samples: serological tests and culture of mononuclear cells; Analysis of cytokine production

Diastolic Heart Failure, or Hypertensive Heart Disease Clinical Trial using DASH/sodium-restricted diet (SRD)

University of Michigan - Recruiting 50 years or older.
- Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet on Ventriculovascular Function in Heart Failure With Preserved Systolic Function.
DASH/sodium-restricted diet (SRD)

Pulmonary Hypertension, or Pulmonary Resistance Clinical Trial using immunoadsorption / immunglobulin substitution

University Medicine Greifswald - Recruiting 18 years or older.
- Randomized, Prospective Investigation on the Effects of Immunoadsorption on Pulmonary Vascular Resistance in Patients With Pulmonary Hypertension.
immunoadsorption / immunglobulin substitution

Hypertension Clinical Trial using Stress Management Training

National Center for Complementary and Alternative Medicine (NCCAM) - Recruiting 55 years or older.
- Mechanisms of the Relaxation Response in Elderly Hypertensives.
Stress Management Training

Intra-Abdominal Hypertension Clinical Trial using furosemide

Ziekenhuis Netwerk Antwerpen (ZNA) - Recruiting 18 years or older.
- The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Mechanically Ventilated Critically Ill Patients With Secondary Intra-abdominal Hypertension.
furosemide

Hypertension, or Hemodialysis Clinical Trial using BP education and BP self-regulation; Supportive Educative Nursing Intervention

Wayne State University - Recruiting 18 years or older.
- Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention.
BP education and BP self-regulation; Supportive Educative Nursing Intervention

Prevention, Screening, Abdominal Aortic Aneurysms, Peripheral Art Clinical Trial using Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Viborg Hospital - Recruiting 65 years to 74 years.
- Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark.
Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Cardiovascular Disease, Hypertension, Diabetes, or Obesity Clinical Trial using Lay Health Promoter (LHP) with maintenance

University of Texas Southwestern Medical Center - Recruiting 18 years to 70 years.
- The GoodNEWS (Genes, Nutrition, Exercise, Wellness, and Spiritual Growth) Trial.
Lay Health Promoter (LHP) with maintenance

Open Angle Glaucoma, or Ocular Hypertension Clinical Trial using laser trabeculoplasty

Santa Clara Valley Health & Hospital System - Recruiting 18 years or older.
- Prospective Evaluation of the Efficacy of Pascal Trabeculoplasty: A Pilot Study.
laser trabeculoplasty

Hypertension Clinical Trial using High blood pressure treatment

National Heart, Lung, and Blood Institute (NHLBI) - Recruiting 10 years to 18 years.
- Neurocognitive Function in Children With Hypertension.
High blood pressure treatment

Cardiovascular Diseases, Heart Diseases, or Hypertension Clinical Trial using Personal Education Program - Next Generation (PEP-NG)

National Heart, Lung, and Blood Institute (NHLBI) - Recruiting 60 years or older.
- Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension.
Personal Education Program - Next Generation (PEP-NG)

Pulmonary Hypertension Clinical Trial using Sildenafil (Viagra); Sildenafil; Placebo

St. Michael's Hospital, Toronto - Recruiting 18 years or older.
- A Phase II, Double Blind Randomized Controlled Trial to Determine the Safety and Efficacy of 12.5mg of Oral Sildenafil (Viagra) Compared to Placebo to Decrease Pulmonary Hypertension in Cardiac Patients After Cardiopulmonary Bypass.
Sildenafil (Viagra); Sildenafil; Placebo

Hypertension Clinical Trial using NanoGreens; Whey protein; Calcium pills

Logan College of Chiropractic - Recruiting 20 years to 70 years.
- Effects of Nutritional Supplements on Blood Pressure and Heart Rate Variability.
NanoGreens; Whey protein; Calcium pills

Congenital Heart Disease Clinical Trial using sildenafil citrate

Oslo University Hospital - Recruiting 16 years to 25 years.
- Pulmonary Hypertension in Adolescents and Adults With Congenital Heart Disease.
sildenafil citrate

Diabetes Mellitus, Hypertension, Dyslipidemia, Obesity, Cardiovas Clinical Trial using Intensive Education for Metabolic Syndrome Patients

Rajavithi Hospital - Recruiting 16 years or older.
- The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-Cohort Study).
Intensive Education for Metabolic Syndrome Patients

Essential Hypertension Clinical Trial using Imidapril; Candesartan

University of Pavia - Recruiting 18 years to 65 years.
- Randomized, Controlled, Parallel Arm, PROBE Study to Evaluate Different Effects of Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension.
Imidapril; Candesartan

Glaucoma, or Ocular Hypertension Clinical Trial using brimonidine 0.1%; Apraclonidine 0.5%

Walter Reed Army Medical Center - Recruiting 18 years or older.
- Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty.
brimonidine 0.1%; Apraclonidine 0.5%

Essential Hypertension Clinical Trial using OJP-2028

Jeil Pharmaceutical Co., Ltd. - Recruiting 18 years to 75 years.
- A 8-Week, Randomized, Double-Blind, Parallel Designed, Phase II Multi-Center Clinical Trial to Evaluate the Antihypertensive Efficacy and the Safety of OJP-2028 Tablets in Patients With the Uncomplicated Essential Hypertension.
OJP-2028

Type 2 Diabetes Mellitus, or Hypertension Clinical Trial using Intensive therapy Valsartan,Fluvastatin

Kitasato University - Recruiting 20 years or older.
- Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension.
Intensive therapy Valsartan,Fluvastatin

Diabetes, Hypertension, or Dyslipidemia Clinical Trial using MEDIC

Providence VA Medical Center - Recruiting 18 years to 85 years.
- Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes.
MEDIC

Essential Hypertension Clinical Trial using telmisartan plus hydrochlorothiazide

Tokyo University - Recruiting 40 years to 80 years.
- ONgoing Evaluation of Depressor Effect And Safety of Combination Therapy With Telmisartan and Low-Dose Hydrochlorothiazide in Patients With Hypertension Uncontrolled on Amlodipine Treatment.
telmisartan plus hydrochlorothiazide

Hypertension, Insulin Resistance, or Dyslipidemia Clinical Trial using Telmisartan

Stanford University - Recruiting 10 years to 18 years.
- Randomized, Placebo Controlled, Double Blind Trial of Telmisartan in Hypertensive, Obese Adolescents.
Telmisartan

Chronic Kidney Disease, or Hypertension Clinical Trial using Procedure: Regional phenylephrine arterial infusion

University of Michigan - Recruiting 18 years to 55 years.
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide.
Procedure: Regional phenylephrine arterial infusion